# US Artificial Heart Market > US Artificial Heart Market Research Report: Size, Share, Trend Analysis By Types (Heart-Lung Machine, Mechanical Heart, Total Artificial Hearts, Ventricular Assist Devices (VADs) and By End Users (Hospitals & Clinics, Specialty Centers) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 9.22% - **2024:** $ 542.13 Million - **2025:** $ 592.11 Million - **2035:** $ 1,430 Million - **Key Players:** Abbott (US), Medtronic (US), Boston Scientific (US), Cleveland Heart (US), Carmen (DE), SynCardia (US), Jarvik Heart (US), Aortech (GB) **Report ID:** MRFR/HC/18036-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** May 13, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-artificial-heart-market-19583 --- ## Market Summary ## **US Artificial Heart Market Overview** ### **Market Size and Growth** As per MRFR analysis, the US Artificial Heart Market Size was estimated at 1.05 (USD Billion) in 2023. The US Artificial Heart Market Industry is expected to grow from 1.25 (USD Billion) in 2024 to 6 (USD Billion) by 2035. The US Artificial Heart Market CAGR (growth rate) is expected to be around 15.327% during the forecast period (2025 - 2035). ### **Key US Artificial Heart Market Trends Highlighted** The US Artificial Heart Market is witnessing significant trends driven by advancements in technology and increasing patient needs. One of the key market drivers is the rising prevalence of cardiovascular diseases, which is a leading cause of death in the United States. As the population ages and lifestyle-related ailments increase, more patients are looking for heart replacement options. Innovations in artificial heart technology, including improved design, biocompatibility, and miniaturization, are further driving market growth. Opportunities are emerging in the development of next-generation devices that promise enhanced functionality and longevity, catering not only to patients awaiting heart transplants but also to those who may not qualify for traditional surgery. Recently, there has been a growing focus on the integration of artificial hearts with digital health technologies, enabling better patient monitoring and data collection. This digital shift allows for real-time health management and personalized treatment plans, making artificial heart therapy more effective and accessible. Additionally, the rise of outpatient surgical procedures is transforming how patients receive artificial heart interventions, reducing hospital stays and costs involved with traditional methods. Various initiatives and support from healthcare organizations in the US aim to promote awareness of artificial heart options, which is fostering acceptance among both patients and healthcare professionals. Research into new materials and designs continues to expand, creating further opportunities for innovation in the US market. With the combination of advanced technology, a growing patient base, and supportive healthcare policies, the US Artificial Heart Market is poised for substantial growth in the coming years. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Artificial Heart Market Drivers** ### **Increasing Prevalence of Cardiovascular Diseases** The US [Artificial Heart Market](../../../reports/artificial-heart-market-7985) Industry is being significantly driven by the rising incidence of cardiovascular diseases among the population. According to the Centers for Disease Control and Prevention (CDC), about 697,000 individuals in the United States died from heart disease in 2020, accounting for 1 in every 5 deaths. This alarming statistic underscores a critical health issue that is fostering the growth of the artificial heart market. As the population ages and lifestyle diseases become more common, the demand for advanced heart failure treatments, including artificial hearts, is anticipated to escalate. Furthermore, organizations such as the American Heart Association are actively promoting awareness and education on heart health, pushing advancements in innovative treatment options which in turn catalyzes market growth and innovation in the artificial heart sector. ### **Technological Advancements in Artificial Heart Technologies** Rapid technological advancements are a vital driver for the US Artificial Heart Market Industry. Innovations in materials and design, backed by extensive Research and Development (R&D) efforts from various medical device firms like Abbott Laboratories and Medtronic, are making artificial hearts more efficient and reliable. Newer iterations exhibit longer durability and better patient outcomes. For instance, the development of continuous-flow left ventricular assist devices (LVADs) has greatly improved heart function in patients awaiting transplants. The Food and Drug Administration (FDA) has also been more proactive in approving devices, with a reported increase of 20% in expeditious device approvals during the past five years, enabling quicker market entry for groundbreaking technologies. ### **Rising Awareness and Acceptance of Advanced Heart Technologies** Increasing awareness and acceptance of advanced medical technologies among both healthcare providers and patients are propelling the US Artificial Heart Market Industry forward. According to a survey conducted by the American College of Cardiology, over 70% of patients with heart diseases express openness to using artificial heart technologies upon receiving adequate education concerning the risks and benefits. Moreover, public campaigns led by organizations such as the National Heart, Lung, and Blood Institute are working towards increasing understanding of heart failure management options, thereby fostering a more accepting atmosphere for artificial heart solutions. This shift in mindset helps drive growth in adoption rates of artificial heart procedures as more patients seek advanced treatments. ### **Supportive Regulatory Environment and Reimbursement Policies** The US Artificial Heart Market Industry is also being positively affected by favorable regulatory environments and evolving reimbursement policies. The Centers for Medicare & Medicaid Services (CMS) have recognized and updated reimbursement frameworks to provide better compensation for heart failure treatments, including artificial hearts. This adjustment has been evident in the increase in reimbursement rates for related procedures by approximately 15% over the last three years, thus encouraging healthcare providers to adopt and implement advanced technologies. Additionally, with the introduction of newer procedural codes exploring the treatment of advanced heart failure, the artificial heart sector stands to gain significantly from a more business-friendly environment, leading to heightened innovation and adoption. ## **US Artificial Heart Market Segment Insights** ### **Artificial Heart Market Type Insights** The US Artificial Heart Market is diverse and segmented primarily by Type, revealing a comprehensive landscape characterized by significant advancements in medical technology. Within this segment, the Heart-Lung Machine is crucial for providing cardiac and respiratory support during surgeries, illustrating its essential role in complex procedures, particularly in cardiothoracic operations. Mechanical Hearts serve as a pivotal alternative for patients experiencing severe heart failure, acting as a temporary solution while patients await transplants, thereby addressing the shortage of available donor organs. Total Artificial Hearts represent a remarkable innovation that can replace the heart entirely, providing life-altering capabilities for patients with end-stage heart disease and illustrating advancements in device reliability and patient outcomes. Ventricular Assist Devices (VADs) have gained considerable traction as they assist heart function and blood flow in patients with weakened hearts, making them a vital component in heart failure management and supporting patients prior to and following heart transplantation. The growing prevalence of heart diseases in the US, coupled with advancements in surgical techniques and device technology, underscores the importance of each type within the market. Furthermore, increasing investment in Research and Development activities within the healthcare sector is poised to drive innovations in the artificial heart space, further bolstering the capabilities and efficacy of these devices. The overall aging population, combined with rising cardiovascular disorders, enhances the urgency for robust solutions encapsulated within these segment types. The integration of cutting-edge technology and data-driven healthcare approaches aligns with the evolving needs of patients and healthcare providers, reflecting robust potential in market growth. As such, each segment thrives under increasing focus on improving patient care, outcomes, and quality of life, establishing the US Artificial Heart Market as a multi-faceted and essential part of the broader healthcare environment. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Artificial Heart Market End User Insights** The End User segment of the US Artificial Heart Market plays a vital role in accommodating the growing demand for artificial heart technologies, primarily through Hospitals and Clinics, as well as Specialty Centers. Hospitals and Clinics are significant hubs for cardiac care, providing essential procedures and follow-up services for patients with severe heart conditions. They typically have specialized personnel and technological capabilities to effectively manage complex heart procedures, which enhances patient outcomes and fosters technological advancements in artificial heart devices. Specialty Centers focus on treating specific heart conditions with tailored interventions, leading to improved diagnostic and therapeutic efficiency. They often attract patients who are seeking advanced treatment options, reinforcing their importance in the overall healthcare ecosystem. The collaborative nature of these End Users supports research and development initiatives, driving continuous innovations in artificial hearts. Additionally, the increasing prevalence of heart diseases in the US further emphasizes the relevance of these facilities, as they are crucial for delivering state-of-the-art care to a growing patient population. Overall, the strategic positioning of Hospitals and Clinics alongside Specialty Centers in the US Artificial Heart Market enables them to effectively meet the dynamic healthcare demands of patients with cardiac ailments. ## **US Artificial Heart Market Key Players and Competitive Insights** The US Artificial Heart Market is characterized by intense competition among key players who are striving to innovate and improve their product offerings. As the prevalence of heart diseases continues to escalate, the demand for artificial hearts to treat severe cases of heart failure is rising. Various companies are focusing on research and development to create devices that enhance patient outcomes and address the limitations of existing technologies. The market landscape is influenced by several factors, including regulatory approvals, technological advancements, partnerships, and collaborations that companies pursue to stay ahead in the competitive scenario. With an increasing aging population and growing awareness about cardiovascular diseases, companies are continuously looking to capture market share through differentiated product strategies and effective marketing initiatives. Medtronic, a leading player in the US Artificial Heart Market, has established a significant presence due to its robust range of cardiovascular devices and solutions. The company is known for its innovative ventricular assist devices, which are crucial for patients who are not candidates for heart transplants or are awaiting transplantation. Medtronic's strengths lie in its comprehensive research and clinical programs aimed at validating the effectiveness of its products. The company’s commitment to advancing technology for cardiac support is evident in its continuous investment in R&D, helping to maintain a competitive edge. Additionally, Medtronic benefits from an extensive distribution network and collaborations with healthcare systems, which enable it to reach a wider patient base and enhance its market penetration across the United States. Abbott Laboratories is another formidable entity in the US Artificial Heart Market, recognized for its advancements in heart implant technologies. The company offers a variety of products like left ventricular assist devices and has made notable advancements in heart failure management. With a strong portfolio, Abbott Laboratories strengthens its position through its commitment to innovation and a focus on patient-centric solutions. The company has engaged in strategic mergers and acquisitions to amplify its capabilities and expand its technological reach within the cardiovascular sector. These initiatives have not only provided Abbott with enhanced expertise but have also produced synergies that bolster its market presence. The combination of a diverse product line, strong R&D focus, and strategic partnerships contributes to Abbott Laboratories' competitive strengths in the US Artificial Heart Market. ### **Key Companies in the US Artificial Heart Market Include** ## **US Artificial Heart Market Industry Developments** The US Artificial Heart Market has seen significant developments recently. In October 2023, Medtronic announced advancements in their cardiac devices, promising improved patient outcomes and extending the lifespan of artificial hearts. Abbott Laboratories continues to focus on innovation, recently unveiling new clinical data supporting their heart pump systems. Boston Scientific is also actively participating in clinical trials aimed at enhancing device efficiency and patient care. On the mergers and acquisitions front, Terumo Cardiovascular Systems officially acquired certain assets related to heart pump technology from a smaller firm in September 2023, enhancing their portfolio in this sector. The market valuation for companies like LifeTech Scientific and St. Jude Medical has shown growth due to rising demand for heart assist devices, bolstered by an increasing number of heart failure cases in the US. Moreover, the collaboration between Cleveland Clinic and SynCardia Systems in November 2022 has been pivotal in integrating advanced technology into cardiac care. These trends indicate a robust market environment driven by medical breakthroughs and strategic partnerships. Major developments in the last few years indicate a focus on patient-centered innovations and technological advancements in artificial hearts, critically impacting therapy options available in the US. ## **US Artificial Heart Market Segmentation Insights** ### **Artificial Heart Market Type Outlook** ### **Artificial Heart Market End User Outlook** ## Market Drivers ### Increased Healthcare Expenditure The rising healthcare expenditure in the US is a significant driver for the artificial heart market. With healthcare spending projected to reach $6 trillion by 2027, there is a growing emphasis on advanced medical technologies, including artificial hearts. This increase in spending is partly due to the aging population and the rising incidence of chronic diseases. The artificial heart market stands to benefit from this trend, as healthcare providers seek to invest in cutting-edge solutions that improve patient outcomes. Furthermore, the expansion of insurance coverage for advanced cardiac devices is likely to enhance accessibility, thereby driving market growth. As a result, the artificial heart market may see a surge in demand as more patients gain access to these life-saving technologies. ### Supportive Regulatory Environment A supportive regulatory environment is fostering growth in the artificial heart market. The US Food and Drug Administration (FDA) has streamlined the approval process for innovative cardiac devices, which encourages manufacturers to bring new products to market more quickly. This regulatory support is crucial for the artificial heart market, as it reduces the time and cost associated with product development. As of 2025, the FDA has approved several new artificial heart models, which has expanded treatment options for patients. This proactive approach by regulatory bodies is likely to stimulate competition and innovation within the market, ultimately benefiting patients. The artificial heart market may continue to thrive as regulatory frameworks evolve to support advancements in cardiac technology. ### Rising Incidence of Cardiovascular Diseases The increasing prevalence of cardiovascular diseases in the US is a primary driver for the artificial heart market. According to the American Heart Association, cardiovascular diseases account for approximately 1 in every 4 deaths in the US. This alarming statistic highlights the urgent need for advanced treatment options, including artificial hearts. As the population ages and lifestyle-related health issues become more common, the demand for artificial heart solutions is expected to rise. The artificial heart market is likely to experience substantial growth, with projections indicating a market value exceeding $3 billion by 2027. This trend underscores the critical role that artificial hearts will play in addressing the healthcare challenges posed by cardiovascular diseases. ### Technological Innovations in Cardiac Devices Technological advancements in cardiac devices are significantly influencing the artificial heart market. Innovations such as miniaturization, improved biocompatibility, and enhanced battery life are making artificial hearts more viable for patients. The integration of smart technology, including remote monitoring capabilities, is also enhancing patient outcomes and satisfaction. As of 2025, the artificial heart market is projected to grow at a CAGR of around 15%, driven by these technological innovations. Companies are investing heavily in research and development to create next-generation devices that offer better performance and longevity. This focus on innovation is likely to attract more patients and healthcare providers to consider artificial hearts as a viable treatment option. ### Growing Awareness and Acceptance of Artificial Hearts There is a notable increase in awareness and acceptance of artificial hearts among patients and healthcare professionals. Educational initiatives and advocacy groups are playing a crucial role in informing the public about the benefits and advancements in artificial heart technology. This growing awareness is likely to lead to higher patient acceptance rates, which is essential for the artificial heart market. As of 2025, surveys indicate that approximately 70% of patients are open to considering artificial hearts as a treatment option for severe heart failure. This shift in perception is expected to drive demand, as more patients seek out these innovative solutions. The artificial heart market may experience accelerated growth as acceptance continues to rise. ## Future Outlook The [Artificial Heart Market](https://www.marketresearchfuture.com/reports/artificial-heart-market-7985) is projected to grow at a 9.22% CAGR from 2025 to 2035, driven by technological advancements, increasing patient demand, and enhanced healthcare infrastructure. **New opportunities:** - Development of AI-driven predictive analytics for patient monitoring systems. Expansion of telehealth services for remote patient management. Partnerships with insurance providers for coverage of advanced heart technologies. By 2035, the artificial heart market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Type: Mechanical heart (Largest) vs. Ventricular assist devices (Fastest-Growing) The share distribution within the segment reveals that the mechanical heart is the largest contributor, holding a significant portion of the market. Following closely are ventricular assist devices, which are rapidly gaining traction due to advancements in technology and increasing patient demand. Heart-lung machines and total artificial hearts occupy smaller segments but are vital for specific patient needs. Growth trends in this segment are primarily driven by an aging population, rising incidences of heart disease, and technological innovations that enhance the efficacy of devices. Furthermore, increasing investment in R&D initiatives and favorable regulatory frameworks are propelling the adoption of ventricular assist devices, making them one of the fastest-growing segments in the market. Technology: Mechanical heart (Dominant) vs. Ventricular assist devices (Emerging) The mechanical heart stands out as the dominant technology in the US artificial heart market, characterized by its established reliability and effectiveness in managing severe cardiac conditions. It is widely utilized in clinical settings for patients requiring long-term support. Conversely, ventricular assist devices are emerging as a revolutionary option, with technology evolving rapidly, leading to miniaturization and improved patient outcomes. These devices are increasingly favored in both surgical and non-surgical interventions, appealing to patients and healthcare providers alike. The competitive edge for ventricular assist devices lies in their adaptability and potential to be used in less invasive procedures, positioning them strongly for future growth. ### By End-User: Hospitals (Largest) vs. Clinics (Fastest-Growing) In the US artificial heart market, hospitals take the largest share, dominating the landscape due to their comprehensive cardiovascular care capabilities. This segment effectively capitalizes on established medical infrastructure and advanced technology, making hospitals the go-to choice for serious heart conditions. Clinics, while smaller in market share, are rapidly increasing their foothold by offering specialized services and convenience for patients requiring artificial heart evaluations. The growth trends within this segment reflect a shift in patient preferences toward more accessible healthcare solutions, including outpatient services provided by clinics. The rise of telehealth and the increased focus on preventive care are also driving factors. As technological advancements continue to evolve, both hospitals and clinics are adjusting strategies to meet demands for innovative treatments, further propelling their market positioning. Hospitals (Dominant) vs. Clinics (Emerging) Hospitals represent the dominant force in the US artificial heart market, equipped with specialized staff, advanced equipment, and the capacity to handle complex surgical procedures. They provide comprehensive care from diagnosis to post-operative rehabilitation, hence attracting a large patient base. Conversely, clinics are emerging as important players, focusing on outpatient services that cater to patients seeking convenience and personalized care. These healthcare facilities are increasingly implementing advanced technologies and fostering specialized heart teams. As the healthcare landscape evolves, both segments complement each other, with hospitals providing intensive care and clinics amplifying outreach and accessibility. ## Competitive Benchmarking The artificial heart market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing patient demand for innovative cardiac solutions. Key players such as Abbott (US), Medtronic (US), and SynCardia (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Abbott (US) focuses on innovation, particularly in developing next-generation heart pumps, while Medtronic (US) emphasizes strategic partnerships to expand its product offerings. SynCardia (US) is leveraging its expertise in total artificial hearts to capture a larger share of the market, indicating a trend towards specialization among competitors. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market appears moderately fragmented, with several players vying for dominance. However, the collective influence of major companies like Abbott (US) and Medtronic (US) suggests a trend towards consolidation, as these firms seek to optimize their operations and enhance their competitive edge. In October 2025, Abbott (US) announced a partnership with a leading research institution to develop AI-driven algorithms for patient monitoring, which could significantly enhance post-operative care for artificial heart patients. This strategic move underscores Abbott's commitment to integrating advanced technology into its product offerings, potentially improving patient outcomes and solidifying its market leadership. In September 2025, Medtronic (US) launched a new line of minimally invasive heart pumps, aimed at addressing the growing demand for less invasive surgical options. This initiative not only reflects Medtronic's focus on innovation but also positions the company to capture a broader patient demographic, thereby enhancing its competitive stance in the market. In August 2025, SynCardia (US) expanded its manufacturing capabilities by investing in a new facility dedicated to the production of its total artificial hearts. This expansion is likely to increase production efficiency and meet the rising demand for artificial heart devices, further establishing SynCardia as a key player in the market. As of November 2025, the artificial heart market is witnessing trends such as digitalization and the integration of AI technologies, which are reshaping competitive dynamics. Strategic alliances are becoming increasingly important, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on technological advancements and supply chain reliability, suggesting that companies that prioritize innovation will likely emerge as leaders in this evolving landscape. ## Recent News & Developments The US Artificial Heart Market has seen significant developments recently. In October 2023, Medtronic announced advancements in their cardiac devices, promising improved patient outcomes and extending the lifespan of artificial hearts. Abbott Laboratories continues to focus on innovation, recently unveiling new clinical data supporting their heart pump systems. Boston Scientific is also actively participating in clinical trials aimed at enhancing device efficiency and patient care. On the mergers and acquisitions front, Terumo Cardiovascular Systems officially acquired certain assets related to heart pump technology from a smaller firm in September 2023, enhancing their portfolio in this sector. The market valuation for companies like LifeTech Scientific and St. Jude Medical has shown growth due to rising demand for heart assist devices, bolstered by an increasing number of heart failure cases in the US. Moreover, the collaboration between Cleveland Clinic and SynCardia Systems in November 2022 has been pivotal in integrating advanced technology into cardiac care. These trends indicate a robust market environment driven by medical breakthroughs and strategic partnerships. Major developments in the last few years indicate a focus on patient-centered innovations and technological advancements in artificial hearts, critically impacting therapy options available in the US. ## Report Scope | MARKET SIZE 2024 | 542.13(USD Million) | | --- | --- | | MARKET SIZE 2025 | 592.11(USD Million) | | MARKET SIZE 2035 | 1430.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.22% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Abbott (US), Medtronic (US), Boston Scientific (US), Cleveland Heart (US), Carmen (DE), SynCardia (US), Jarvik Heart (US), Aortech (GB) | | Segments Covered | Type, End-User | | Key Market Opportunities | Advancements in biocompatible materials enhance performance and patient outcomes in the artificial heart market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the artificial heart market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US artificial heart market in 2024?** A: The market valuation was 542.13 USD Million in 2024. **Q: What is the projected market valuation for the US artificial heart market by 2035?** A: The projected valuation for 2035 is 1430.0 USD Million. **Q: What is the expected CAGR for the US artificial heart market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 9.22%. **Q: Which companies are considered key players in the US artificial heart market?** A: Key players include Abbott, Medtronic, Boston Scientific, Cleveland Heart, Carmen, SynCardia, Jarvik Heart, and Aortech. **Q: What are the main segments of the US artificial heart market?** A: The main segments include Heart-lung machines, Mechanical hearts, Total artificial hearts, and Ventricular assist devices. **Q: What was the valuation range for Ventricular assist devices in 2024?** A: The valuation range for Ventricular assist devices was 212.13 to 530.0 USD Million in 2024. **Q: How do hospitals and clinics compare in terms of market valuation for artificial hearts?** A: In 2024, hospitals had a valuation of 217.0 to 570.0 USD Million, while clinics ranged from 162.0 to 420.0 USD Million. **Q: What is the valuation range for Total artificial hearts in 2024?** A: The valuation range for Total artificial hearts was 100.0 to 300.0 USD Million in 2024. **Q: What segment is expected to show the highest growth in the US artificial heart market?** A: The Mechanical heart segment, with a valuation range of 150.0 to 400.0 USD Million, may show substantial growth. **Q: What is the projected growth trend for healthcare centers in the US artificial heart market?** A: Healthcare centers had a valuation range of 163.13 to 440.0 USD Million in 2024, indicating potential growth. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-artificial-heart-market-19583*